Drugs / FC-12738
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05978908 | Feb → Jun 2024 | — | Neurodegenerative Disease Research Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FC-12738 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05978908 ↗ |
| Modality | Peptide | “Retro enversio pentapeptide of thymopentin” NCT05978908 ↗ |